WEALTH UNIVERSITY

[hotdog1012]

I'm listening to the conference call now. Sounds very good. They're addressing the mixed results that occured (and was reported) back in January.

They brought on a couple heavy weight doctors on their staff who have deep experience in clinical trials and FDA submission

Secondly, they've done very extensive studies of the mixed data, they brought in an independent consulting group to help and they've determined not only the cause of the mixed results, but they've also been able to confirm the accuracy of the Appyscore.

Thirdly, they've identified how the Appyscore will be a consumable instrument where a doctor would typically use 2-3 of these consumables per patient to monitor the progression. $ cha-ching! $

Now filing for 510 clearance with the FDA.

It sounds like this is going back on track...will this get back to the $5-$6 range? Sounds like it should, imo...